Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase II data presented on AIC-246 for human cytomegalovirus infection

Jan. 3, 2011

Anti-HIV-1 activity of aciclovir and potentiation by ribavirin

Jan. 3, 2011

Selective SYK inhibitors P505-15 and P459-72 show anticancer potential

Jan. 3, 2011

HER2-Affitoxin is a potential therapeutic for HER2-overexpressing tumors

Dec. 31, 2010

CADA blocks HIV entry by disrupting translocation of CD4 across ER membrane

Dec. 31, 2010

Preclinical and clinical data presented on BEZ-235

Dec. 31, 2010

Efficacy and safety data from ECHO and THRIVE trials of rilpivirine reported

Dec. 31, 2010

DermaPrep-delivered LC-002 shows promise in phase I/II trials in HIV

Dec. 31, 2010

[18F]-Marimastat-aryltrifluoroborate described as useful for PET imaging of breast cancer

Dec. 30, 2010

Scientists unveil mechanism leading to resistance of HIV to maraviroc

Dec. 30, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...